Form SC 13D ModivCare Inc Filed by: Q Global Capital Management, L.P.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
MODIVCARE INC.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
60783X104
(CUSIP Number)
Nelson Holm
301 Commerce Street, Suite 3200
Fort Worth, Texas 76102
(817) 332-9500
... (continue reading...)
Form 3 JUPITER NEUROSCIENCES, For: Nov 08 Filed by: Brady Allison W
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 3 JUPITER NEUROSCIENCES, For: Nov 08 Filed by: Silva Alison D.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 3 JUPITER NEUROSCIENCES, For: Nov 08 Filed by: ROSEN CHRISTER
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 3 JUPITER NEUROSCIENCES, For: Nov 08 Filed by: Rosen Alexander Gustaf Erik
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
More SEC Filings
View Older Stories-
Form 3 JUPITER NEUROSCIENCES, For: Nov 08 Filed by: Kampf Julie B.
-
Form 3 JUPITER NEUROSCIENCES, For: Nov 08 Filed by: Weis Holger
-
Form 3 JUPITER NEUROSCIENCES, For: Nov 08 Filed by: Elmasri Saleem
-
Form 3 JUPITER NEUROSCIENCES, For: Nov 08 Filed by: Hayward Marshall A.
-
Form 3 JUPITER NEUROSCIENCES, For: Nov 08 Filed by: Hemmerly Nicholas H.
-
Form SC 13D Evotec SE Filed by: Excalibur LuxCo SARL
-
Form 4 ALPHA & OMEGA SEMICONDUC For: Nov 08 Filed by: Chang Stephen Chunping
-
Form 4 P10, Inc. For: Nov 06 Filed by: COVENANT RHA PARTNERS, L.P.
-
Form 4 ADT Inc. For: Nov 08 Filed by: Apollo Management, L.P.
-
Form 4 Verb Technology Company, For: Nov 08 Filed by: MOY EDMUND C.
-
Form 4 Verb Technology Company, For: Nov 08 Filed by: CUTAIA RORY J.
-
Form 4 Verb Technology Company, For: Nov 08 Filed by: Geiskopf James P
-
Form 4 Verb Technology Company, For: Nov 08 Filed by: CRAGUN KENNETH S
-
Form 4 MANNKIND CORP For: Nov 06 Filed by: Tross Stuart A
-
Form 4 Verb Technology Company, For: Nov 08 Filed by: Rivard Bill John
-
Form 4 Ares Management Corp For: Nov 06 Filed by: Berry Ryan
-
Form 4 ENSIGN GROUP, INC For: Nov 06 Filed by: Snapper Suzanne D.
-
Form 4 ENSIGN GROUP, INC For: Nov 06 Filed by: Keetch Chad
-
Form 4 ENSIGN GROUP, INC For: Nov 06 Filed by: Burton Spencer
-
Form 4 ENSIGN GROUP, INC For: Nov 06 Filed by: Port Barry
-
Form 4 ENSIGN GROUP, INC For: Nov 06 Filed by: Christensen Christopher R.
-
Form SC 13G/A Bioventus Inc. Filed by: Spindletop Healthcare Capital, L.P.
-
Form 144 VSE CORP Filed by: KOONCE CALVIN SCOTT
-
Form 4 PROCORE TECHNOLOGIES, For: Nov 06 Filed by: Fleming William Fred Jr
-
Form 4 PROCORE TECHNOLOGIES, For: Nov 07 Filed by: Fu Howard
-
Form 4 Candel Therapeutics, For: Nov 06 Filed by: Aguilar Laura K.
-
Form 4 FLEX LTD. For: Nov 06 Filed by: Stevens Charles K. III
-
Form 4 Vaxcyte, Inc. For: Nov 07 Filed by: Cowan Elvia
-
Form 4 Vaxcyte, Inc. For: Nov 07 Filed by: Eydelman Mikhail
-
Form 4 Vaxcyte, Inc. For: Nov 07 Filed by: Wassil Jim
-
Form 4 Vaxcyte, Inc. For: Nov 07 Filed by: GUGGENHIME ANDREW
-
Form 4 Vaxcyte, Inc. For: Nov 07 Filed by: PICKERING GRANT
-
Form 4 AYTU BIOPHARMA, INC For: Nov 06 Filed by: DOCKERY CARL
-
Form 4 ALPHA & OMEGA SEMICONDUC For: Nov 07 Filed by: Chang Lucas S.
-
Form 4 ALPHA & OMEGA SEMICONDUC For: Nov 07 Filed by: SALAMEH MICHAEL J
-
Form 4 ALPHA & OMEGA SEMICONDUC For: Nov 07 Filed by: OWYANG KING
-
Form 4 ALPHA & OMEGA SEMICONDUC For: Nov 07 Filed by: Chen Claudia
-
Form 4 ALPHA & OMEGA SEMICONDUC For: Nov 07 Filed by: Pfeiffer Michael L
-
Form 4 ALPHA & OMEGA SEMICONDUC For: Nov 07 Filed by: Jeong So-Yeon
-
Form 4 ALPHA & OMEGA SEMICONDUC For: Nov 07 Filed by: Li Hanqing
-
Form 4 DevvStream Corp. For: Nov 06 Filed by: Focus Impact Sponsor, LLC
-
Form SC 13G/A Airsculpt Technologies, Filed by: Rollins Aaron
-
Form 4 AYTU BIOPHARMA, INC For: Nov 06 Filed by: Donofrio John Jr.
-
Form 4/A National Bank Holdings For: Nov 05 Filed by: Van Denabeele Nicole
-
Form 4 W.W. GRAINGER, INC. For: Nov 06 Filed by: Berardinelli Krantz Nancy L
-
Form 4 AYTU BIOPHARMA, INC For: Nov 06 Filed by: JAIN ABHINAV
-
Form 144 Stellantis N.V. Filed by: Knight Natalie
-
Form 4 Landsea Homes Corp For: Nov 06 Filed by: Hartfield Thomas
-
Form SC 13G/A Viant Technology Inc. Filed by: Vanderhook Timothy
-
Form SC 13G/A Viant Technology Inc. Filed by: Vanderhook Christopher